Hyperuricemia, gout and comorbidity
Hyperuricemia is most often combined with lipid metabolism disorders, modifiable risk factors for coronary heart disease, stroke, abdominal obesity, type 2 diabetes mellitus, arterial hypertension, urolithiasis, chronic kidney disease. Current data indicate the presence of pro-inflammatory, pro-oxid...
Saved in:
| Main Authors: | N. A. Shostak, N. G. Pravdyuk, T. K. Loginova, G. N. Lazarenko |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2023-01-01
|
| Series: | Klinicist |
| Subjects: | |
| Online Access: | https://klinitsist.abvpress.ru/Klin/article/view/511 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gout: possibilities of treatment optimization
by: A. A. Klimenko, et al.
Published: (2024-12-01) -
Type 2 diabetes mellitus and gout
by: O. V. Zhelyabina, et al.
Published: (2021-10-01) -
UPDATED EULAR GUIDELINES FOR THE MANAGEMENT OF GOUT. COMMENTS ON CERTAIN ITEMS
by: M. S. Eliseev
Published: (2018-01-01) -
Febuxostat in the therapy of gout: from theory to practice
by: E. V. Ilyinykh, et al.
Published: (2018-01-01) -
Commentaries on the updated American College of Rheumatology guidelines for the management of gout. Urate-lowering drugs (Part 1)
by: M. S. Eliseev
Published: (2020-09-01)